Agilent ZORBAX XDB-C8 Procainamide Metabolites Application Note

This document describes the separation performance of ZORBAX XDB-C8 for Procainamides and metabolites at a pH of 7.0 or higher. It provides good peak shape and resolution, making it suitable for pharmaceutical applications.


Agilent ZORBAX XDB-C8 Procainamide Metabolites Application Note - cover page
Brand
Agilent
Document type
Application Note
Language
English
Pages
2
File format
PDF
File size
267 KB
Published
03 July, 2012
Updated
28 September, 2023
Model
XDB-C8
MD5 checksum
40E4D5304080BE88A6FC45A5BE8E6B2F

About this manual

The document details a chromatographic method for separating procainamide, n-acetylprocainamide, and n-propionylprocainamide. It highlights that while USP assays often use pH 7.5, the ZORBAX XDB-C8 column provides superior peak shape and resolution at intermediate pH levels (e.g., 7.0) due to its extra-dense bonding and double endcapping which shields active silanols.

The provided method utilizes a mobile phase of 20 mM NaHPO4 (pH 7.0) with acetonitrile, an injection volume of 5 µL, a flow rate of 1.5 mL/min, and a column temperature of 40°C.

What's inside

  • Application
  • Highlights
  • Conditions

Frequently asked questions

What are the dimensions of the ZORBAX XDB-C8 column used in this application?

The column used in this application has dimensions of 4.6x 150 mm.

What is the injection volume and flow rate for the separation procedure?

The procedure requires an injection of 5pL and a flow rate of 1.5 mL/min.

Download PDF (267 KB)

More Agilent Manuals


View all Agilent manuals →